Experienced in Herpes Simplex Encephalitis

Isik S. Johansen

Sønder Boulevard 29, 
Odense, DK 
Experienced in Herpes Simplex Encephalitis
Sønder Boulevard 29, 
Odense, DK 
OverviewLocationsClinical Research

Overview

Isik Johansen practices in Odense, Denmark. Johansen is rated as an Experienced expert by MediFind in the treatment of Herpes Simplex Encephalitis. Their top areas of expertise are HIV/AIDS, Severe Acute Respiratory Syndrome (SARS), Tuberculous Meningitis, Pulmonary Tuberculosis, and Kidney Transplant.

Their clinical research consists of co-authoring 221 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Herpes Simplex Encephalitis.

Locations

Sønder Boulevard 29, Odense, 5000, Denmark

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Microbiome-based Stratification of Individuals at Risk of HIV-1 Acquisition, Chronic Clinical Complications, Antimicrobial Drug Resistance, and Unresponsiveness to Therapeutic HIV-1 Vaccination
Microbiome-based Stratification of Individuals at Risk of HIV-1 Acquisition, Chronic Clinical Complications, Antimicrobial Drug Resistance, and Unresponsiveness to Therapeutic HIV-1 Vaccination
Enrollment Status: Active_not_recruiting
Publish Date: April 11, 2025
A Phase III, Randomized, Multicenter, Open-label, Non-inferiority Study Evaluating the Efficacy, Safety and Tolerability of Switching to Dolutegravir/Lamivudine Fixed Dose Combination in HIV-1 Infected Adults Who Are Virologically Suppressed
A Phase III, Randomized, Multicenter, Open-label, Non-inferiority Study Evaluating the Efficacy, Safety and Tolerability of Switching to Dolutegravir/Lamivudine Fixed Dose Combination in HIV-1 Infected Adults Who Are Virologically Suppressed
Enrollment Status: Completed
Publish Date: October 19, 2023
Intervention Type: Drug
Study Drugs: Dolutegravir+Lamivudine, Current antiretroviral regimen
Study Phase: Phase 3
View 1 Less Clinical Trial

221 Total Publications

Epidemiology of erysipelas and necrotising soft tissue infections.
Epidemiology of erysipelas and necrotising soft tissue infections.
Journal: Danish medical journal
Published: September 10, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Johansen's expertise for a condition
ConditionClose
    View All 35 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile